Searched over 200M research papers for "nad booster"
10 papers analyzed
These studies suggest NAD+ boosters have potential benefits for age-related diseases, muscle insulin sensitivity, inflammation, hematopoiesis, and mitochondrial function, but more clinical trials are needed to determine proper doses, durations, and long-term safety.
20 papers analyzed
Nicotinamide adenine dinucleotide (NAD+) is a crucial metabolite involved in energy metabolism and various biochemical reactions, including protein deacylation, ADP-ribosylation, and cyclic ADP-ribose synthesis. These processes are mediated by enzymes such as sirtuins, poly (ADP-ribose) polymerases (PARPs), and CD38. NAD+ levels naturally decline with age, contributing to metabolic and age-related diseases, making the maintenance of NAD+ levels a significant focus in translational medicine.
NAD+ boosters work through several mechanisms, including the use of NAD+ precursors, modulation of NAD+ biosynthesis enzymes, and inhibition of NAD+ consuming enzymes. Common NAD+ precursors include nicotinamide (NAM), nicotinamide riboside (NR), and nicotinamide mononucleotide (NMN) . These compounds can be taken as dietary supplements and have shown potential in mimicking calorie restriction, which is known to have various health benefits.
NAD+ boosters have shown promise in preclinical studies for their ability to counteract age-related metabolic disorders. For instance, clinical evidence suggests that NAD+ boosters can improve muscle insulin sensitivity in postmenopausal prediabetic women, highlighting their potential in human health. Additionally, NAD+ restoration in aged or diseased animals has been linked to improved health and extended lifespan, suggesting a broad therapeutic potential.
In rheumatoid arthritis (RA) patients, NAD+ metabolism is significantly altered, with reduced NAD+ levels and increased expression of NAD+-consuming genes. Studies have shown that NAD+ boosters can restore NAD+ levels, reduce oxidative stress, apoptosis, and inflammation in leukocytes from RA patients, indicating their potential as novel therapeutic tools for RA .
Nicotinamide riboside (NR), a potent NAD+ booster, has been shown to stimulate hematopoiesis by increasing mitochondrial clearance, leading to improved survival and accelerated blood recovery in murine models. This suggests that NR could be beneficial for patients suffering from hematological failures, such as those undergoing chemotherapy or radiotherapy.
In patients with adult-onset mitochondrial myopathy, NAD+ deficiency has been observed. Treatment with niacin, a form of vitamin B3, significantly increased NAD+ levels in blood and muscle, improved muscle performance, and reduced liver fat, demonstrating the efficacy of NAD+ boosters in treating mitochondrial disorders.
Despite the promising results, there are still uncertainties regarding the optimal dosage, timing, safety, and long-term effects of NAD+ boosters. More clinical trials are needed to determine the appropriate use of these supplements for aging prevention and disease therapy. Additionally, innovative approaches, such as the development of small molecule activators of NAD+ biosynthesis enzymes like NAMPT, are being explored to enhance the efficiency of NAD+ production.
NAD+ boosters hold significant potential in improving health and treating various age-related and metabolic diseases. While current research is promising, further studies are necessary to fully understand the long-term effects and optimal usage of these compounds. As our understanding of NAD+ metabolism and its role in health continues to grow, NAD+ boosters may become a cornerstone in the fight against aging and chronic diseases.
Most relevant research papers on this topic